Flex

1600 Main Street
Venice
California
90291
United States

Tel: 800-931-0882

About Flex

The Flex Company is the leader in innovation for feminine care, and the sole maker of menstrual discs™. Menstrual discs are the first product innovation in feminine hygiene in nearly a century and offer 12 hours of leak-free period protection and mess-free period sex. Today women in over 40 countries use our patented menstrual disc products, FLEX and Softcup. Over 250 million discs have been sold worldwide.
Founded in 2015, The Flex Company is in Venice Beach, California, and a part of Amplify.LA and Y Combinator.
The Flex Company is female founded, owned and led. We believe in a world where every woman loves her body. Learn more at flexfits.com.
YEAR FOUNDED:
May 2015
LEADERSHIP
Founder and CEO: Lauren Schulte
Co-Founder: Head of Growth & Acquisition: Erika Jensen
Co-Founder: Head of Operations: Panpan Wang
JOBS:
Please click here for Flex job opportunities.
FOLLOW FLEX:
Tweets by Flex

12 articles about Flex

With the Launch of FLEX at Target, Everyone Can Help Design The Future of Period Products

4/16/2019

The partnership marks a turning point for accessibility in period product innovation
BrightInsight, a Flex Company, Receives 2018 Google Cloud Partner of the Year Award for Healthcare and Life Sciences

4/9/2019

Built on Google Cloud Platform, the BrightInsight Platform supports and optimizes regulated drugs, devices and software through integrated data and actionable insights
Flex Digital Health Announces Novo Nordisk as BrightInsight Customer

10/23/2018

Companies to Develop Digital Health Solutions to Improve Diabetes Care
Flex Announces BrightInsight Clinical Board to Advance Development of Digital Solutions for Pharma and Medtech

9/12/2018

Flex has assembled a clinical advisory board to leverage the perspectives of leading doctors for the development of powerful digital health solutions that integrate into and improve clinical workflow to make a real-world impact on patient outcomes.
Flex Pharma Reports Third Quarter 2017 Financial Results

11/6/2017

Flex reported financial results for the quarter ended September 30, 2017 and provided an update on its clinical development and corporate activities.
Flex Pharma Reports Positive Topline Data From Exploratory Phase II Trial of FLX-787 in ALS

11/6/2017

The study was terminated early to focus the Company’s resources on the ongoing US Phase 2b ALS study (COMMEND).
Former Inotek Executive Jumps Ship to Flex as CEO

7/31/2017
Flex’s Phase II Trial With FLX-787 In Charcot-Marie-Tooth Endorsed By The Inherited Neuropathies Consortium

6/2/2017
FDA Clears Flex's FLX-787 To Commence U.S. Phase II Trial In ALS Under IND

4/26/2017
Flex Presents Human Efficacy Data On FLX-787 At American Academy of Neurology Annual Meeting

4/19/2017
Flex Appoints Dr. Kal Patel As Senior Vice President Of Digital Health

11/2/2016
Flex, The Tampon Alternative You Can Wear During Sex

8/15/2016